Effects of Canagliflozin on microbiota and glycometabolism, kidney function of patients with diabetic nephropathy
Phase of Trial: Phase II
Latest Information Update: 26 Mar 2018
At a glance
- Drugs Canagliflozin (Primary)
- Indications Diabetic nephropathies
- Focus Therapeutic Use
- 23 Mar 2018 Status changed from active, no longer recruiting to discontinued.
- 25 Jul 2017 Status changed from recruiting to active, no longer recruiting.
- 25 Jul 2016 Status changed from not yet recruiting to recruiting.